Worldwide Leader in Hair Testing For Drugs of Abuse Recognized Internationally For Highest Quality Laboratory Standards ACTON, Mass., Nov. 7, 2011 /PRNewswire/ — Psychemedics Corporation, hair testing for drugs of abuse pioneer and leader for 25 years, announced today that its laboratory has received international accreditation (ISO/IEC 17025:2005) for a broad spectrum of laboratory testing … Read more
Acton, Massachusetts, November 3, 2011 — Psychemedics Corporation (NASDAQ:PMD) today announced third quarter financial results for the period ended September 30, 2011. The Company also announced a quarterly dividend of $0.12 per share payable to shareholders of record as of November 17, 2011 to be paid on December 1, 2011. This will be the Company’s … Read more
News Release PSYCHEMEDICS CORPORATION ANNOUNCES SALES & MARKETING AGREEMENT WITH BUPA IN UK Acton, Massachusetts, May 19, 2009 – Psychemedics Corporation (NASDAQ: PMD) today announced that it has signed a sales and marketing agreement with leading international health and care organization Bupa, to market the patented Psychemedics hair analysis drug test in the UK. Around … Read more
NEWS RELEASE Contact: Raymond Ruddy Vice President and Controller (978) 206-8220 Raymondr@psychemedics.com PSYCHEMEDICS CORPORATION DECLARES A $.50/SHARE SPECIAL DIVIDEND Acton, Massachusetts, November 17, 2008 — Psychemedics Corporation (NASDAQ: PMD) today announced a special dividend of $.50 per share payable December 24, 2008, to shareholders of record on December 10, 2008. Raymond C. Kubacki, Chairman, and … Read more
NEWS RELEASE Contact: Raymond C. Kubacki Chairman, President, and CEO (978) 206-8220 RAYMOND J. RUDDY JOINS PSYCHEMEDICS CORPORATION AS TOP FINANCIAL OFFICER Acton, Massachusetts, October 20, 2008 – Psychemedics Corporation (NASDAQ: PMD) today announced that Raymond J. Ruddy has joined the company as Vice President, Controller. Ray will be responsible for all internal and external … Read more